{"transactions":[{"id":932720,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-01-23T16:05:14.000Z","date":"2026-01-21","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on January 21, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":2.57,"expiration_date":"2036-01-20","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001895913-26-000002","document":"form4-01232026_040111.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000189591326000002/form4-01232026_040111.xml","form_type":"4"}},{"id":1290065,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-01-31T16:35:46.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on January 30, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":125000,"derivative":{"exercise_price":2.52,"expiration_date":"2035-01-29","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001415889-25-002489","document":"form4-01312025_090143.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000141588925002489/form4-01312025_090143.xml","form_type":"4"}},{"id":1290064,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2025-01-31T16:35:46.000Z","date":"2025-01-30","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\") under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 50% of the RSUs shall vest on January 30, 2026 and the remaining 50% of the RSUs shall vest on January 30, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":85150,"source":{"system":"sec-edgar","filing":"0001415889-25-002489","document":"form4-01312025_090143.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000141588925002489/form4-01312025_090143.xml","form_type":"4"}},{"id":1641804,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-15T17:34:08.000Z","date":"2024-02-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest and become exercisable on February 14, 2025, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":4.86,"expiration_date":"2034-02-13","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001415889-24-003960","document":"form4-02152024_100202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000141588924003960/form4-02152024_100202.xml","form_type":"4"}},{"id":2014265,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-15T16:11:10.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on February 13, 2024, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":60000,"derivative":{"exercise_price":2.92,"expiration_date":"2033-02-12","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001104659-23-022388","document":"tm236831-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000110465923022388/tm236831-4_4seq1.xml","form_type":"4"}},{"id":2014264,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2023-02-15T16:11:10.000Z","date":"2023-02-13","kind":"grant","acquired":true,"shares":5075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The Reporting Person was previously granted performance-based Restricted Stock Units (\"RSUs\"). The vesting of 35% of the RSUs was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,776 RSUs, with the remainder vesting on August 15, 2023, subject to the grantee's continuous service through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person was previously granted performance-based Restricted Stock Units (\"RSUs\"). The vesting of 35% of the RSUs was subject to the achievement of certain performance criteria. As of the transaction date, the performance criteria were met, resulting in the vesting of 1,776 RSUs, with the remainder vesting on August 15, 2023, subject to the grantee's continuous service through such vesting date."}],"balance_after":10150,"source":{"system":"sec-edgar","filing":"0001104659-23-022388","document":"tm236831-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000110465923022388/tm236831-4_4seq1.xml","form_type":"4"}},{"id":2389769,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-17T16:17:56.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":20300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest and become exercisable on February 15, 2023, with the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":20300,"derivative":{"exercise_price":3.79,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":20300},"source":{"system":"sec-edgar","filing":"0001415889-22-001515","document":"form4-02172022_010228.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000141588922001515/form4-02172022_010228.xml","form_type":"4"}},{"id":2389768,"issuer":{"id":6669,"kind":"organization","name":"Black Diamond Therapeutics, Inc.","symbol":"BDTX"},"owners":[{"id":68944,"kind":"person","name":"Jones Erika","position":1,"cik":"0001895913","reported_name":"Jones Erika","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SEE REMARKS"}}],"security":"Common Stock","published_at":"2022-02-17T16:17:56.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":5075,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\") under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 35% on the 9 month anniversary of February 15, 2022 (the \"Vesting Commencement Date\"), 35% on the 18 month anniversary of the Vesting Commencement Date, and the remaining 30% on the 27 month anniversary of the Vesting Commencement Date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a grant of Restricted Stock Units (\"RSUs\") under the Black Diamond Therapeutics, Inc. 2020 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's common stock. The RSUs shall vest as follows: 35% on the 9 month anniversary of February 15, 2022 (the \"Vesting Commencement Date\"), 35% on the 18 month anniversary of the Vesting Commencement Date, and the remaining 30% on the 27 month anniversary of the Vesting Commencement Date."}],"balance_after":5075,"source":{"system":"sec-edgar","filing":"0001415889-22-001515","document":"form4-02172022_010228.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1895913/000141588922001515/form4-02172022_010228.xml","form_type":"4"}}]}